可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Wang GK,Zhu JQ,Zhang JT,et al.Circulating microRNA:a novel potential biomarker for early diagnosis of acute myocardial infarction in humans[J].Eur Heart J,2010,31(6):659-666.
[2]Corsten MF,Dennert R,Jochems S,et al.Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease[J].Circ Cardiovasc Genet,2010,3(6):499-506.
[3]Cheng Y,Tan N,Yang J,et al.A translational study of circulating cell-free microRNA-1 in acute myocardial infarction[J].Clin Sci(Lond),2010,119(2):87-95.
[4]D'alessandra Y,Devanna P,Limana F,et al.Circulating microRNAs are new and sensitive biomarkers of myocardial infarction[J].Eur Heart J, 2010,31(22):2765-2773.
[5]Gidl?f O,Andersson P,van der Pals J,et al.Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination,and can be detected in urine samples[J].Cardiology,2011,118(4):217-226.
[6]Widera C,Gupta SK,Lorenzen JM,et al.Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome[J].J Mol Cell Cardiol,2011,51(5):872-875.
[7]Li C,Fang Z,Jiang T,et al.Serum microRNAs profile from genome-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris[J].BMC Med Genomics,2013,6:16.
[8]Eitel I,Adams V,Dieterich P,et al.Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction[J].Am Heart J,2012,164(5):706-714.
[9] Gidl?f O,Smith JG,Miyazu K,et al.Circulating cardio-enriched microRNAs are associated with long-term prognosis following myocardial infarction[J].BMC Cardiovasc Disord,2013,13:12.
[10]Yao Y,Zhou X,Wang XB,et al.Changes in cardiac specific microRNA-208a level in peripheral blood in ST segment elevation acute myocardial infarction patients[J].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2012, 24(12):717-720.
[11]Callis TE,Pandya K,Seok HY,et al.MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice[J].J Clin Invest,2009,119(9):2772-2786.
[12]Terentyev D,Belevych AE, Terentyeva R,et al.miR-1 overexpression enhances Ca(2+)release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2[J].Circ Res,2009,104(4):514-521.
[13]Sayed D,He M,Hong C,et al.MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand[J].J Biol Chem,2010,285(26):20281-20290.
[14]van Rooij E,Sutherland LB,Thatcher JE,et al.Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis[J].Proc Natl Acad Sci U S A,2008,105(35):13027-13032.
[15]He B,Xiao J,Ren AJ,et al.Role of miR-1 and miR-133a in myocardial ischemic postconditioning[J].J Biomed Sci,2011,18:22.
[16]Tang Y,Zheng J,Sun Y,et al.MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2[J].Int Heart J,2009,50(3):377-387.